Randomized controlled trial of irinotecan drug-eluting beads with simultaneous FOLFOX and bevacizumab for patients with unresectable colorectal liver-limited metastasis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Randomized controlled trial of irinotecan drug-eluting beads with simultaneous FOLFOX and bevacizumab for patients with unresectable colorectal liver-limited metastasis

Published:2015-07-06 Issue:20 Volume:121 Page:3649-3658
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Martin Robert C. G.¹²,Scoggins Charles R.¹²,Schreeder Marshall³,Rilling William S.⁴,Laing Christopher J.⁵,Tatum Clifton M.⁶,Kelly Lawrence R.⁶,Garcia-Monaco Ricardo D.⁷,Sharma Vivek R.²⁸,Crocenzi Todd S.⁹,Strasberg Steven M.¹⁰

Affiliation:

1. Division of Surgical Oncology; University of Louisville School of Medicine; Louisville Kentucky

2. James Graham Brown Cancer Center; Louisville Kentucky

3. Clearview Cancer Institute; Huntsville Alabama

4. Froedtert Medical College; Milwaukee Wisconsin

5. Interventional Radiology, Sutter Health; Sacramento California

6. Norton Radiology Associates; Louisville Kentucky

7. Hospital Italiano; Buenos Aires Argentina

8. Division of Medical Oncology; University of Louisville School of Medicine; Louisville Kentucky

9. Providence Medical Center; Portland Oregon

10. Siteman Cancer Center; Washington University in Saint Louis/Barnes-Jewish Hospital; Saint Louis Missouri

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/cncr.29534/fullpdf

Reference31 articles.

1. Liver resection for colorectal metastases in presence of extrahepatic disease: results from an international multi-institutional analysis;Pulitano;Ann Surg Oncol,2011

2. High survival rate after two-stage resection of advanced colorectal liver metastases: response-based selection and complete resection define outcome;Brouquet;J Clin Oncol,2011

3. Systemic cytotoxic and biological therapies of colorectal liver metastases: expert consensus statement

4. Phase III trial of infusional fluorouracil, leucovorin, oxaliplatin, and irinotecan (FOLFOXIRI) compared with infusional fluorouracil, leucovorin, and irinotecan (FOLFIRI) as first-line treatment for metastatic colorectal cancer: the Gruppo Oncologico Nord Ovest;Falcone;J Clin Oncol,2007

5. Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial;Nordlinger;Lancet,2008

Cited by 131 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Third-line treatment and beyond in metastatic colorectal cancer: What do we have and what can we expect?;Critical Reviews in Oncology/Hematology;2024-10

2. Transarterial (chemo)embolisation versus systemic chemotherapy for colorectal cancer liver metastases;Cochrane Database of Systematic Reviews;2024-08-09

3. Local-Regional Therapy for Oligometastatic Colorectal Cancer;The Cancer Journal;2024-07

4. Drug-eluting beads transcatheter arterial chemoembolization combined with systemic therapy versus systemic therapy alone as first-line treatment for unresectable colorectal liver metastases;Frontiers in Oncology;2024-04-24

5. Prognostic factors for overall survival and safety of trans-arterial chemoembolization (TACE) with irinotecan-loaded drug-eluting beads (DEBIRI) in patients with colorectal liver metastases;Radiology and Oncology;2024-03-30

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3